The FDA in September issued two rejections for spinal muscular atrophy therapies—both linked to manufacturing problems—and ...

Closed-loop targeted deep brain stimulation holds promise in addressing symptoms of depression and obsessive-compulsive ...

ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill children, a ...

The alfa pump® system received U.S. FDA Premarket Approval in December 2024 for the treatment of recurrent or refractory ascites due to liver cirrhosis. It is the first active implantable medical ...

Background Hospitalisation with acute heart failure (AHF) carries a high risk of death, and those surviving to discharge ...

As we approach the first anniversary of flooding from Hurricane Helene that devastated parts of North Carolina, the ...

Beginning dialysis is the start of a major life transition for many Americans impacted by chronic kidney disease. About two ...

Your body maintains a delicate balance between the water you consume and the amount you use. Most of the water you drink is quickly removed from your body, but the time it takes for this process to ...

Aquaglyceroporin Aqp10, a protein channel for water and glycerol, selectively permeates urea and boric acid due to its unique ...

Unlock your fastest, strongest runs yet with this high-intensity interval method that pushes endurance and shatters plateaus.

Research indicates that repetition and distributed practice are effective methods for strengthening memory and enhancing ...

IMPACT-HTN, a novel initiative to modernize hypertension care, has been launched by Idorsia at Stanford Hypertension Center and Duke Heart Center.